Related references
Note: Only part of the references are listed.50-Year Trends in Smoking-Related Mortality in the United States
Michael J. Thun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort
Louise A. Brinton et al.
CANCER CAUSES & CONTROL (2012)
Hormone therapy and breast cancer risk 10 years after the WHI
A. Gompel et al.
CLIMACTERIC (2012)
The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis
Yonggang Zhang et al.
BMC MEDICAL GENETICS (2011)
The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Menopausal Hormone Therapy Does Not Influence Lung Cancer Risk: Results from the California Teachers Study
Jessica Clague et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Reproductive and hormonal factors and the risk of nonsmall cell lung cancer
Cari L. Meinhold et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis
Emma J. Crosbie et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Lung Cancer and Hormone Replacement Therapy: Association in the Vitamins and Lifestyle Study
Christopher G. Slatore et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Lung Cancer Among Postmenopausal Women Treated With Estrogen Alone in the Women's Health Initiative Randomized Trial
Rowan T. Chlebowski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Coronary heart disease and hormone replacement therapy after the menopause
H. N. Hodis et al.
CLIMACTERIC (2009)
The HRT controversy: observational studies and RCTs fall in line
Jan P. Vandenbroucke
LANCET (2009)
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial
Rowan T. Chlebowski et al.
LANCET (2009)
Hormone use and lung cancer incidence: the Rancho Bernardo cohort study
Joshua R. Smith et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Dietary boron and hormone replacement therapy as risk factors for lung cancer in women
S. Mahabir et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort
Carmen Rodriguez et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Data Analysis Methods and the Reliability of Analytic Epidemiologic Research
Ross L. Prentice
EPIDEMIOLOGY (2008)
Benefits and Risks of Drug Treatments How to Combine the Best Evidence on Benefits With the Best Data About Adverse Effects
Jan P. Vandenbroucke et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Hormone replacement therapy and lung cancer risk in Chinese
Kuan-Yu Chen et al.
CANCER (2007)
Reproductive and hormonal factors and risk of lung cancer in women: A prospective cohort study
Geoffrey C. Kabat et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Hormone replacement therapy as a risk factor for non-small cell lung cancer: Results of a case-control study
N. Ramnath et al.
ONCOLOGY (2007)
Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study
AM Elliott et al.
CONTRACEPTION (2006)
Hormone replacement therapy is associated with decreased survival in women with lung cancer
AK Ganti et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: A large-scale population-based cohort study
Y Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Progesterone receptor in non-small cell lung cancer - A potent prognostic factor and possible target for endocrine therapy
H Ishibashi et al.
CANCER RESEARCH (2005)
Lung cancer in women - Emerging differences in epidemiology, biology, and therapy
L Thomas et al.
CHEST (2005)
Hormone replacement therapy in cancer survivors
N Biglia et al.
MATURITAS (2004)
Hormone replacement therapy and lung cancer risk: A case-control analysis
MB Schabath et al.
CLINICAL CANCER RESEARCH (2004)
Hormonal factors and risk of lung cancer among women?
M Kreuzer et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2003)
Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer
KA Moore et al.
ANNALS OF THORACIC SURGERY (2003)
Estrogen replacement therapy and risk of lung cancer
JA Blackman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Hormone replacement therapy and coronary heart disease in women: A review of the evidence
AK Low et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Noncardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II)
S Hulley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Expression, function, and clinical implications of the estrogen receptor β in human lung cancers
Y Omoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Incidence of cancer among women using long versus monthly cycle hormonal replacement therapy, Finland 1994-1997
E Pukkala et al.
CANCER CAUSES & CONTROL (2001)
Share Paper
